Caas Capital Management LP
- SEC CIK
- 0001802881
- Latest filing
- May 1, 2025
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Caas Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q1 2025 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q1 2022